Vidac Pharma Holding Plc

As of December 31, 2025, Vidac Pharma Holding Plc carries a market capitalization of 33.04M, placing it among publicly traded companies globally. Its enterprise value stands at 33.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Vidac Pharma Holding Plc has 56.95M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Vidac Pharma Holding Plc maintains a current ratio of 0.51, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.

As of the close on October 23, 2026, Vidac Pharma Holding Plc's stock has declined approximately 31.61% over the past 52 weeks. The 50-day moving average sits at 0.40, while the 200-day moving average is 0.55.

As of December 31, 2025, Vidac Pharma Holding Plc holds 286,696.94 in cash and equivalents against 361,238.14 in total debt, resulting in a net debt position of 74,541.20. Total book value stands at -725,916.65, with working capital of -729,357.01 providing operational flexibility.